FAIRDOMHubModelsAfsaneh Maleki-Dizajihttps://fairdomhub.org/models/18?version=1University of SheffieldFAIRDOMHubDRUG, Alkalescens-Dispar Group, agent, Bacterium coli, Oxygen 16, single-organism developmental process, Product, therapeutic_agents, postnatal development, drug, bacterium E3, E-948, growth and development, TRT, 8O, EAggEC, model, Enteroaggregative E. coli, oxygen, Agent, development, Pharmacologic Agent, dioxygene, Diffusely Adherent E. coli, Sauerstoff, Bacillus coli, responsivity, Escherchia coli, oxigeno, Pharmacologic Substance, StudyAgent, Enteroinvasive Escherichia coli, Enterococcus coli, study treatment, oxygene, E948, Models, Protocol Agent, OXYGEN MOLECULE, Basic, availability., reactivity, O2, Modeling System, Diffusely Adherent Escherichia coli, Disauerstoff, dioxygen, Investigational Therapy or Treatment, Escherichia/Shigella coli, Model System, Enteroinvasive E. coli, therapeutic agents, Pharmaceutical Agent, O, AGENT, Pharmacological Substance, Oxygen-16, postnatal growth, Basis, E coli, GDC Therapeutic Agent Terminology, study agent, Based, Drug Substance, E. coli, Drug, Eschericia coli, Enteroaggregative Escherichia coli, Oxygen, Bacterium coli commune, [OO], Base, Study Agent, response, Model, E 948, growth, molecular oxygen, Dioxygen, PharmaceuticalsDRUG, Alkalescens-Dispar Group, agent, Bacterium coli, Oxygen 16, single-organism developmental process, Product, therapeutic_agents, postnatal development, drug, bacterium E3, E-948, growth and development, TRT, 8O, EAggEC, model, Enteroaggregative E. coli, oxygen, Agent, development, Pharmacologic Agent, dioxygene, Diffusely Adherent E. coli, Sauerstoff, Bacillus coli, responsivity, Escherchia coli, oxigeno, Pharmacologic Substance, StudyAgent, Enteroinvasive Escherichia coli, Enterococcus coli, study treatment, oxygene, E948, Models, Protocol Agent, OXYGEN MOLECULE, Basic, availability., reactivity, O2, Modeling System, Diffusely Adherent Escherichia coli, Disauerstoff, dioxygen, Investigational Therapy or Treatment, Escherichia/Shigella coli, Model System, Enteroinvasive E. coli, therapeutic agents, Pharmaceutical Agent, O, AGENT, Pharmacological Substance, Oxygen-16, postnatal growth, Basis, E coli, GDC Therapeutic Agent Terminology, study agent, Based, Drug Substance, E. coli, Drug, Eschericia coli, Enteroaggregative Escherichia coli, Oxygen, Bacterium coli commune, [OO], Base, Study Agent, response, Model, E 948, growth, molecular oxygen, Dioxygen, PharmaceuticalsfalseDevelopment of agent-based models describing the response of Escherichia coli to changes in oxygen availabilityDevelopment of agent-based models describing the response of Escherichia coli to changes in oxygen availability2009-10-262009-10-262009-10-262009-10-2618